Orthofix Medical Inc. President Reinhardt Max sells 1643 shares at $11.64 on June 11.
ByAinvest
Friday, Jun 13, 2025 4:27 pm ET1min read
OFIX--
The sale of shares by a high-ranking executive can sometimes influence market perception, but in this case, the transaction was specifically for tax purposes. The stock price of OFIX has been volatile in recent days, with shares falling 2.90% in mid-day trading on June 12, 2025. The stock reached an intraday low of $10.95 before recovering slightly to $11.05, down from its previous close of $11.38 [2]. This places OFIX 46.70% below its 52-week high of $20.73 and 5.24% above its 52-week low of $10.50 [2].
Wall Street analysts have forecasted an average target price for OFIX of $24.40, with a high estimate of $27.20 and a low estimate of $22.00 [2]. This suggests an average upside of 120.81% from the current price of $11.05. The consensus recommendation from brokerage firms is "Outperform" [2]. GuruFocus estimates the GF Value for OFIX to be $16.84 in one year, suggesting an upside of 52.4% from the current price of $11.05 [2].
References:
[1] https://www.tradingview.com/news/tradingview:69a163b7c2904:0-orthofix-medical-officer-sells-shares-to-cover-tax-obligations/
[2] https://www.gurufocus.com/news/2924698/orthofix-medical-inc-ofix-stock-price-down-29-on-jun-12
Orthofix Medical Inc. (OFIX) has reported that President, Global Spine Reinhardt Max has divested 1643 shares at a price of $11.64 per share on June 11, 2025.
Orthofix Medical Inc. (OFIX) has reported that its President of Global Spine, Max Reinhardt, sold 1,643 shares of common stock on June 11, 2025, at a price of $11.64 per share, totaling $19,124 [1]. This transaction was to satisfy tax withholding obligations related to the settlement of restricted stock units, as mandated by the company's Compensation and Talent Development Committee. Following this sale, Reinhardt directly owns 27,481 shares of Orthofix Medical, including 24,324 restricted stock units previously reported [1].The sale of shares by a high-ranking executive can sometimes influence market perception, but in this case, the transaction was specifically for tax purposes. The stock price of OFIX has been volatile in recent days, with shares falling 2.90% in mid-day trading on June 12, 2025. The stock reached an intraday low of $10.95 before recovering slightly to $11.05, down from its previous close of $11.38 [2]. This places OFIX 46.70% below its 52-week high of $20.73 and 5.24% above its 52-week low of $10.50 [2].
Wall Street analysts have forecasted an average target price for OFIX of $24.40, with a high estimate of $27.20 and a low estimate of $22.00 [2]. This suggests an average upside of 120.81% from the current price of $11.05. The consensus recommendation from brokerage firms is "Outperform" [2]. GuruFocus estimates the GF Value for OFIX to be $16.84 in one year, suggesting an upside of 52.4% from the current price of $11.05 [2].
References:
[1] https://www.tradingview.com/news/tradingview:69a163b7c2904:0-orthofix-medical-officer-sells-shares-to-cover-tax-obligations/
[2] https://www.gurufocus.com/news/2924698/orthofix-medical-inc-ofix-stock-price-down-29-on-jun-12

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet